David Tapolczay's most recent trade in Conduit Pharmaceuticals Inc was a trade of 840,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Nov. 18, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Conduit Pharma Inc | David Tapolczay | Director, Chief Executive Officer | 18 Nov 2024 | 840,000 | 840,000 | - | - | Stock Option (Right to Buy) | ||
| Conduit Pharma Inc | David Tapolczay | Director, Chief Executive Officer | 22 Apr 2024 | 400,664 | 400,664 | - | - | Warrant (Right to buy) | ||
| Conduit Pharma Inc | David Tapolczay | Director, Chief Executive Officer | 22 Apr 2024 | 200,332 | 200,332 | - | - | Warrant (Right to buy) |